Guangdong Marubi Biotechnology Co (603983) — Cash Flow-to-Debt Ratio
Guangdong Marubi Biotechnology Co (603983) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥43.25 Million could theoretically repay 0% of its total liabilities (CN¥1.46 Billion) in one year. See 603983 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangdong Marubi Biotechnology Co Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Guangdong Marubi Biotechnology Co across 15 annual periods. Also explore net asset growth rate of Guangdong Marubi Biotechnology Co to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guangdong Marubi Biotechnology Co (2011–2025)
Year-by-year debt coverage analysis for Guangdong Marubi Biotechnology Co. For market capitalisation and broader financial context, see Guangdong Marubi Biotechnology Co market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥273.88 Million | CN¥1.22 Billion | ▲ +20.8% |
| 2024 | 0.19x | CN¥300.53 Million | CN¥1.62 Billion | ▼ -43.0% |
| 2023 | 0.33x | CN¥338.02 Million | CN¥1.04 Billion | ▲ +465.4% |
| 2022 | 0.06x | CN¥48.44 Million | CN¥838.64 Million | ▲ +565.7% |
| 2021 | -0.01x | CN¥-7.48 Million | CN¥603.19 Million | ▼ -102.7% |
| 2020 | 0.46x | CN¥362.35 Million | CN¥794.44 Million | ▼ -24.9% |
| 2019 | 0.61x | CN¥465.53 Million | CN¥766.40 Million | ▼ -13.6% |
| 2018 | 0.70x | CN¥516.69 Million | CN¥735.02 Million | ▲ +26.9% |
| 2017 | 0.55x | CN¥356.20 Million | CN¥643.00 Million | ▲ +68.2% |
| 2016 | 0.33x | CN¥213.33 Million | CN¥647.79 Million | ▼ -22.2% |
| 2015 | 0.42x | CN¥275.11 Million | CN¥649.88 Million | ▼ -32.8% |
| 2014 | 0.63x | CN¥376.24 Million | CN¥597.49 Million | ▼ -6.0% |
| 2013 | 0.67x | CN¥325.67 Million | CN¥486.14 Million | ▲ +38.3% |
| 2012 | 0.48x | CN¥227.49 Million | CN¥469.82 Million | ▼ -19.3% |
| 2011 | 0.60x | CN¥269.39 Million | CN¥448.94 Million | — |